Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-06-02 @ 7:54 AM
Study NCT ID:
NCT02179502
Status:
COMPLETED
Last Update Posted:
2015-09-22
First Post:
2014-06-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Single and Multiple Dose of GLPG1690
Sponsor:
Galapagos NV
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GLPG1690-CL-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None